JR10 E-cigarette | Lighting Up the Future of Smoking Alternatives

Jan.14.2025
 JR10 E-cigarette | Lighting Up the Future of Smoking Alternatives

Making smoking healthier and more personalized, the JR10 e-cigarette is specially designed for the UK market and future European markets. With its excellent design and attractive appearance, it stands out as a leader among smoking alternatives.

 

 JR10 E-cigarette | Lighting Up the Future of Smoking Alternatives
The stylish and simple JR10 e-cigarette features a semi-transparent cartridge design and colorful lights that instantly catch the eye.

 

 

Core Highlights: Long-lasting Battery Life and Powerful Performance

 

 

The JR10 is equipped with a 650mAh rechargeable battery, supporting USB-C fast charging. It can be fully charged in less than an hour, allowing you to maintain smooth use whether at home, in the office, or on the go. Coupled with a large 2+10ML semi-transparent cartridge, it supports approximately 10,000 draws, truly achieving a perfect balance of efficiency and long-lasting battery life.

 

Imagine: No need for frequent charging and oil refills, easily meeting the needs of the whole day, making your life more convenient and efficient.

 

 JR10 E-cigarette | Lighting Up the Future of Smoking Alternatives
The semi-transparent cartridge design, makes the oil level clear at a glance, saying goodbye to dry burns and worries; the screen displays the battery level in real-time, making use smarter.

 

 

Colorful Lights Add Fun to the Experience

 

 

Every draw lights up the semi-transparent cartridge with a rainbow of colors, providing a cool visual experience. This is not just a function but also a fashion statement, suitable for modern users who pursue personalization.

 

 

Automatic Airflow Activation Mechanism, Mouth-to-Lung (MTL) Style for a More Natural Fit

 

 

The JR10 adopts an automatic airflow activation mechanism, no button operation is needed, just pick up and use, especially suitable for users who prefer the MTL (mouth-to-lung) drawing style, with a smooth and natural draw.

 

 JR10 E-cigarette | Lighting Up the Future of Smoking Alternatives
Users enjoy the JR10 effortlessly, with the MTL design closer to the traditional smoking sensation, satisfying the need for a real smoking experience.

 

 

Details are King: Thoughtful Design for Every Moment

 

  • Battery Level Screen Display: Always in control of the device status, no need to worry about the battery running out suddenly.
  • 20mg Nicotine Concentration: Precise control of nicotine cravings, meeting needs while complying with the strict regulations of the European market.
  • Semi-transparent cartridge Design: Clear oil level visibility, more worry-free use.

 

 

Born for the Future: A Dual Commitment to Safety and Environmental Sustainability

 

 

As an innovative product focused on the UK and European markets, the JR10 not only complies with local laws and health standards but also offers sustainable choices through more environmentally friendly designs.

 

The above 2+10 product is developed by Lanavape, which has not yet been officially launched on the website.

 

LANAVAPE is a well-known e-cigarette brand factory headquartered in Shenzhen, China, ranking in the top five in the Southeast Asian market and trusted by consumers. The company focuses on the research and production of disposable, Replaceable pod, and open pod-style e-cigarettes. Now, LANAVAPE is actively expanding into the European market, offering healthier and more efficient smoking alternatives to users worldwide.

FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
The U.S. Food and Drug Administration authorized 11 ZYN ULTRA nicotine pouch products made by Swedish Match USA through the premarket tobacco product application pathway on August 21, 2026. Ten of the authorized products have a labeled nicotine content of 9 mg, while ZYN ULTRA Smooth was authorized at 11 mg. The reviews were conducted through FDA’s nicotine pouch PMTA pilot program. FDA has now authorized 43 nicotine pouch products, including 23 through the pilot.
Aug.24
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Managing Director Naeem Shahab Khan met Perlis Mufti Mohd Asri Zainul Abidin on September 17 and presented the company's shift from conventional cigarettes toward alternative products. The mufti said a product could be considered halal if it is clean, its side effects are not harmful or can be controlled, and it does not involve excessive waste. His remarks did not mention IQOS or any other specific PMI product and did not amount to a new product-specific religious ruling. It was at least the second publicly reported engagement between Philip Morris Malaysia and a Malaysian religious institution over cigarette alternatives within six months.
Regulations
Sep.18 by 2Firsts Perspectives
UK ONS Data: Vaping Rate Among Women Aged 25–34 Reaches 18.3%, Compared With 14.4% for Men
UK ONS Data: Vaping Rate Among Women Aged 25–34 Reaches 18.3%, Compared With 14.4% for Men
The vaping rate among women aged 25 to 34 in Great Britain reached 18.3% in 2025, up from 13.7% in 2024 and 8.3% in 2020, according to data from the Office for National Statistics (ONS). The figure was the highest for this group since records began in 2014 and exceeded the 14.4% recorded among men of the same age. Adults aged 25 to 34 also overtook those aged 16 to 24 as the age group with the highest vaping prevalence. Overall, about 5.4 million adults in Great Britain used e-cigarettes in 2025, broadly unchanged from the previous year.
DATA
Oct.13
Product | PIXL Adds 6ml PIXL 5K in UK Alongside 12ml PIXL 8000 as Vape Duty Takes Effect
Product | PIXL Adds 6ml PIXL 5K in UK Alongside 12ml PIXL 8000 as Vape Duty Takes Effect
Vaping brand PIXL has introduced the PIXL 5K reusable prefilled pod device in the UK, featuring a 2ml prefilled pod and a 4ml refill container with a combined e-liquid capacity of 6ml. The device uses 20mg/ml nicotine salt e-liquid and is advertised to deliver up to approximately 5,000 puffs. Available through UK retailers by August 2026, the PIXL 5K sits alongside the existing 12ml PIXL 8000. The UK's Vaping Products Duty took effect on October 1 at £0.22 per millilitre, producing theoretical duty amounts of £1.32 and £2.64 for the two products' respective full refill sets.
product
Oct.10
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07